BHRB Burke & Herbert Financial Services Corp. Insider Trading

Director Barnwell purchased 5,000 shares of BHRB at $62.76 for $313.8K, raising holdings 23.2% to 26.6K shares.

Julian Forrest Jr. Barnwell, a Director, purchased 5,000 shares at $62.76 on 2026-06-03, bringing total holdings to 26,580 shares—a 23.2% increase in position size. The stock currently trades at $63.61, modestly above the purchase price, with the transaction priced 10.3% below the 52-week high of $70.90. Barnwell's same-ticker history at BHRB shows mixed results: of 5 prior purchases, 3 were followed by positive 90-day returns (well-timed at this ticker), though the most recent buys on 2026-05-11 showed minimal upside (+0.9% at 90 days). The company's fundamentals—$27.3M net income, P/E of 10.91, and $1.3B market cap—suggest a stable, modestly valued regional financial services firm. This purchase represents a material accumulation by a board-level insider into a low-volatility equity where he has demonstrated prior buying activity.

Director Riojas purchases 1,300 shares as stock trades below 52-week highs; part of 3-insider buying cluster in 14-day window.

Riojas Jose David, a Burke & Herbert director, acquired 1,300 shares in two open-market purchases on the same day while the stock trades below its 52-week high and has declined over recent months. This buying activity is part of a broader pattern: three insiders at the company purchased shares within a two-week window, suggesting sustained buying interest at current price levels. Riojas has been a consistent buyer, with 18 open-market purchases over the past three years and no sales—though his timing on this ticker has been mixed, with half of his five prior purchases at Burke & Herbert followed by gains over a 90-day horizon and the other half by declines. The company itself is profitable with solid earnings, providing a financially stable backdrop for the insider purchases. The combination of repeated director buying during a period when the stock is off its highs, paired with the company's profitable operations, creates a setup worth monitoring for longer-term investors.

Director Barnwell Forrest buys 5,000 shares at market; stock down from 52-week high but company remains profitable with solid fundamentals.

Barnwell Julian Forrest Jr., a director at Burke & Herbert Financial Services, purchased 5,000 shares at current market prices, marking his 40th open-market purchase in the past three years. This latest buy occurs with the stock trading noticeably below its 52-week high, though the company remains solidly profitable with strong recent earnings. However, Forrest's previous purchases at this company show concerning timing: all five of his prior documented buys at BHRB saw the stock decline in the 30-day period following each purchase, and over a longer 90-day horizon, only one of those five prior buys preceded gains while four saw declines. This mixed-to-poor track record at this specific ticker contrasts with his consistent buying pattern and suggests his previous additions to his BHRB stake have not been well-timed. The current purchase at a lower valuation multiple than the market typically demands could represent another attempt at averaging down, but his prior buying activity provides limited reassurance that he has successfully identified attractive entry points at this company.

Director Barnwell Forrest Jr. buys 5,000 shares of BHRB; stock down from 52-week highs amid conflicting insider track record at this ticker.

Director Barnwell Forrest Jr. purchased 5,000 shares of Burke & Herbert Financial Services at a modest increase to his existing position, adding to a 41-trade open-market buying streak across all holdings over the past three years with zero sales. The stock currently trades well below its 52-week high and has declined notably over the past quarter, creating a typical buying-the-dip environment. However, his track record at this specific ticker tells a cautionary tale: every one of his five prior purchases at BHRB saw the stock decline in the following month, though one of those prior buys eventually recovered and gained modestly over a longer timeframe—a pattern of conflicting short-term and longer-term outcomes. The company itself remains profitable with steady quarterly earnings, suggesting financial stability, yet the stock's recent weakness and this director's uneven prior timing at this ticker create mixed signals about whether this purchase represents genuine conviction or simply another chapter in a choppy execution history at this specific company.

Director Shawn Patrick McLaughlin purchased 1,000 shares of BHRB at $63.55; 3 of 4 prior buys at this ticker showed strong 90-day gains.

Director Shawn Patrick McLaughlin acquired 1,000 shares at $63.55, bringing his holdings to 69,000 shares. Notably, he executed a buy on 2026-04-28 (the day before this trade), suggesting sustained conviction over consecutive trading days. His prior four measurable trades at BHRB show a 3-of-4 success rate on 90-day outcomes: the 2025-10-28 buy returned +5.1%, the 2025-05-29 buy returned +13.5%, and the 2025-05-07 buy returned +1.3%, while only the 2025-02-24 buy resulted in a -11.2% decline. The cumulative evidence of well-timed entry points at this specific ticker—combined with his continued purchasing activity—stands out against his cross-ticker record, which shows only a 57.89% 90-day win rate and -1.0% average 30-day return. Given the company's attractive P/E of 5.08 and the insider's demonstrated track record of favorable entry timing at BHRB, the transaction warrants investor attention.

Director's open-market purchase of 1,000 shares signals confidence in BHRB's fundamentally sound profile.

An insider director purchased 1,000 shares at market price, representing a modest addition to holdings during a period when the stock is trading below its recent highs but showing near-term recovery momentum. The company is profitable with a low valuation multiple and strong quarterly earnings, indicating solid underlying business fundamentals. The timing of this buy—after the stock pulled back but hasn't collapsed—suggests the insider sees value in a fundamentally sound financial services company, rather than panic-buying into a crisis or catching a falling knife. This disciplined, modest accumulation by someone with fiduciary responsibility is a constructive signal, particularly given BHRB's reasonable valuation and consistent profitability. While the purchase size is not dramatic, it reinforces management confidence at a point where the market may be undervaluing the business.

Director McLaughlin buys 1,000 shares of BHRB at $61.00; stock down 13.8% from 52-week high at $71.04

Director Shawn Patrick McLaughlin purchased 1,000 shares of Burke & Herbert Financial Services Corp. at $61.00 on 2025-10-28, increasing his holdings from 66,000 to 67,000 shares. The transaction occurs with the stock trading at $61.26 (current), down 13.8% from its 52-week high of $71.04 and down 2.2% over the past 30 days. Examining McLaughlin's prior trades at BHRB, his timing has been mixed: two of five prior buys showed positive 90-day returns (the May 2025 purchases gaining 6.1% and 1.6% respectively), while three earlier purchases in late January and February 2025 showed 90-day declines ranging from -0.6% to -11.4%. His cross-ticker track record of 20 prior buys shows an average 90-day return of +1.1% with a 50% win rate, suggesting modest overall success timing buys across holdings. The company trades at a P/E of 8.80 with $29.9M net income and a $920.3M market cap, characteristics of a stable small-cap financial services firm.

Director Hinkle buys 1,700 shares at $61.69 avg; weak same-ticker timing history, all 5 prior buys lost 90d value.

Gary L. Hinkle, Director, made 2 purchases totaling 1,700 shares for $104,870.00 at an average price of $61.69 on 2025-09-15. The company's valuation metrics are attractive (P/E of 8.89, net income $29,897,000.00), and the stock is up 10.2% over 90 days from the current price of $61.84. However, his same-ticker purchase history at BHRB shows a concerning pattern: all 5 prior buys resulted in negative 90-day returns ranging from -12.7% to -18.7%, with a 90d win rate of 0 of 5. While his cross-ticker track record shows a 65.00% 90-day win rate, his specific history of buying this stock has not resulted in value appreciation within the 90-day measurement window. The current transaction adds 0.7% to his holdings (250.2K shares post-transaction), a modest accumulation that does not indicate a material shift in position conviction.

Director Riojas bought 500 BHRB shares at $55.85 amid cluster buy by 3 other insiders in 14 days

Director Jose David Riojas purchased 500 shares at $55.85 on 2025-06-05, increasing his position from 18,500 to 19,000 shares, while the stock trades at $56.12 (current price). This buy occurs within a cluster of 4 total insider purchases across 14 days. At the same ticker, Riojas' prior buys show mixed timing outcomes: his 2025-03-06 purchases and 2025-03-11 purchases returned -16.4% and -16.0% respectively over 30 days, with the measurable 90-day outcome from the March 6 trades returning -6.7%. His cross-ticker track record shows 15 prior buys with a 58.33% 90-day win rate and average 90-day return of +13.5%, though his average 30-day return is -5.9%. The company's fundamentals show net income of $27,201,000.00 with a P/E of 14.58 and market cap of $842,104,114.28. The stock has declined 21.0% from its 52-week high of $71.04 and is down 6.9% over 90 days.

Director Anderson Mark Guthrie bought 2,000 shares at blended avg $56.40; now holds 27.7K; stock -20.8% from 52-week high.

Anderson Mark Guthrie, a Director at BHRB, executed two separate purchases on June 2, 2025, totaling 2,000 shares for $112,798.05 at prices near the current market level ($56.28). His post-transaction holdings of 27.7K shares represent a +7.8% increase from his prior 25.7K-share position. The timing context is notable: the stock has declined 20.8% from its 52-week high of $71.04 and is down 8.2% over the past 90 days, yet this purchase comes as part of a cluster pattern with 2 other insiders buying within the past 14 days. At BHRB specifically, Guthrie's prior four completed trades (from Oct 2024 and Feb 2024) show a 0 of 3 well-timed 90-day outcome rate, with the Feb 2024 buy deteriorating to -10.5% by the 90-day mark. The company's fundamentals remain solid with net income of $27,201,000.00 and a P/E of 14.62, though the broader price momentum and Guthrie's historically inconsistent timing at this ticker warrant observation.